Vg Life Valuation
| VGLS Stock | USD 0.0001 0.00 0.00% |
Vg Life seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Vg Life Sciences from evaluating the company fundamentals such as Price To Book of 32.38 X, shares outstanding of 107.88 M, and Return On Asset of -1.51 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Vg Life's price fluctuation is out of control at this time. Calculation of the real value of Vg Life Sciences is based on 3 months time horizon. Increasing Vg Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the VGLS pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Vg Life Sciences. Since Vg Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VGLS Pink Sheet. However, Vg Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 6.3E-5 | Hype 1.0E-4 | Naive 9.3E-5 |
The intrinsic value of Vg Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Vg Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Vg Life Sciences helps investors to forecast how VGLS pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vg Life more accurately as focusing exclusively on Vg Life's fundamentals will not take into account other important factors: Vg Life Total Value Analysis
Vg Life Sciences is at this time expected to have valuation of 4.44 M with market capitalization of 1.82 M, debt of 3.38 M, and cash on hands of 22.92 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Vg Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.44 M | 1.82 M | 3.38 M | 22.92 K |
Vg Life Asset Utilization
One of the ways to look at asset utilization of VGLS is to check how much profit was generated for every dollar of assets it reports. Vg Life Sciences owns a negative utilization of current and long term assets of -1.51 %, losing $0.0151 for each dollar of current and long term assets held by the company. Discouraging asset utilization indicates the company is being less capable with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of Vg Life Sciences shows how wasteful it operates for each dollar spent on its current and long term assets.Vg Life Profitability Analysis
Net Loss for the year was (6.19 M) with profit before overhead, payroll, taxes, and interest of 0.About Vg Life Valuation
The pink sheet valuation mechanism determines Vg Life's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Vg Life Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vg Life. We calculate exposure to Vg Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vg Life's related companies.VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Vg Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Vg Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vg Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Vg Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Vg Life's revenue streams: Identify Vg Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Vg Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Vg Life's growth potential: Evaluate Vg Life's management, business model, and growth potential.
- Determine Vg Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vg Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Vg Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Vg Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 27.6 M | |
| Retained Earnings | -106 M |
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.